• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Inflammatory Breast Cancer International Consortium | IBC-IC HomepageInflammatory Breast Cancer International Consortium | IBC-IC

  • IBC Researchers + Centers
  • What is IBC?
  • About Us
  • Join IBC-IC
  • Research + Clinical Trials
  • Contact Us
  • Donate

< Back to Search Results

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Research + Treatment Center

Location

  • Galter Pavilion
  • 675 N. Saint Clair Street, 21st Floor
  • Chicago, IL, 60611
  • USA
  • Phone: 312.695.0990
  • Fax: 312.695.0991

Visit Website >

About

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University provides state-of-the-art therapies and comprehensive cancer care to patients in two modern outpatient clinical cancer center locations. It is one of only 49 NCI-designated Comprehensive Cancer Centers in the nation. In addition, the Lurie Cancer Center is a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 27 of the world’s leading cancer centers dedicated to quality, effectiveness and efficiency of cancer care so that patients can live better lives. It is also a part of the Big Ten Cancer Research Consortium, a network of academic institutions working together on highly translational clinical trials using the expertise of Big Ten universities. The Lurie Cancer Center is affiliated with four teaching hospitals in Chicago: Northwestern Memorial Hospital, Ann & Robert H. Lurie Children’s Hospital of Chicago, the Shirley Ryan AbilityLab and the Jesse Brown Veteran’s Affairs Medical Center, treating more than 10,000 new cancer cases each year. Learn more about the Robert H. Lurie Comprehensive Cancer Center of Northwestern University >

Areas of Research

  • Brain Tumors
  • Breast Cancer
  • Cancer Nanotechnology
  • Cancer Population Epigenetics
  • Cancer Survivorship
  • Comparative Effectiveness
  • Inflammatory Breast Cancer
  • Metastatic Breast Cancer
  • Prostate Cancer
  • Skin Cancer

Research Divisions

  • Basic Science Research
  • Cancer Prevention and Control Science Research
  • Clinical Sciences Research
  • Behavioral and Population-based Investigations

Accreditations

  • America College of Radiology (ACR) accredited
  • American Board of Radiology (ABR) accredited
  • American College of Radiation Oncology (ACRO) accredited
  • American College of Surgeons (ACoS) Commission on Cancer accredited program (CoC)
  • National Accreditation Program for Breast Centers (NAPBC)
  • National Cancer Institute (NCI) designated cancer center

Affiliations and Memberships

  • Oncofertility Consortium
  • PROMIS® (Patient-Reported Outcomes Measurement Information System)
  • Stanley Manne Children’s Research Institute

Active Clinical Trials

  • NU UW16B13: A Phase II Study of Neratinib Alone and in Combination with Fulvestrant in Metastatic HER2 Non-amplified but HER2 Mutant Breast Cancer
  • NU 17B02: Phase II single arm of BYL719/Alpelisib combined with chemotherapy for neoadjuvant treatment of patients with HER2-negative stage III inflammatory breast cancer (IBC) — I-TARGET-IBC Trial

View all clinical trials at clinicaltrials.gov >

Affiliated IBC-IC Researcher(s)

  • Massimo Cristofanilli, MD, FACP

Join IBC-IC

Become part of our international consortium of centers, clinicians, advocates and centers worldwide dedicated to ending IBC.

Join >

IBCIC.org makes every effort to keep center information as up-to-date as possible.
Contact this center to confirm any information regarding his or her profile.

Footer

Inflammatory Breast Cancer International Consortium
420 E 70th St, LH 206
New York, NY 10021

Contact us

contact@ibcic.org